[1] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075. | [2] | World Health Organization. World health statistics 2018: monitoring health for the SDGs, sustainable development goals[M]. Geneva: WHO, 2018: 6-8. | [3] | Jenkins EJ, Schurer JM, Gesy KM. Old problems on a new playing field: helminth zoonoses transmitted among dogs, wildlife, and people in a changing northern climate[J]. Vet Parasitol, 2011, 182(1): 54-69. | [4] | Wang JH, Müller S, Lin RY, et al. Depletion of FoxP3+ Tregs improves control of larval Echinococcus multilocularis infection by promoting co-stimulation and Th1/17 immunity[J]. Immun Inflamm Dis, 2017, 5(4): 435-447. | [5] | Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected[J]. J Clin Invest, 2015, 125(9): 3356-3364. | [6] | Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells[J]. J Leukoc Biol, 2015, 98(6): 913-922. | [7] | Gabrilovich DI. Myeloid-derived suppressor cells[J]. Cancer Immunol Res, 2017, 5(1): 3-8. | [8] | Pan W, Zhou HJ, Shen YJ, et al. Surveillance on the status of immune cells after Echinnococcus granulosus protoscoleces infection in BALB/c mice[J]. PLoS One, 2013, 8(3): e59746. | [9] | Yu AP, Yin JH, Gong WC, et al. Changes of myeloid-derived suppressor cells and Th17 cells in mice infected with Echinococcus granulosus protoscoleces[J]. Chin J Parasitol Parasit Dis, 2018, 36(3): 224-230. (in Chinese) | | (于爱萍, 尹建海, 巩文词, 等. 细粒棘球蚴感染小鼠髓源抑制性细胞与Th17细胞比例的变化[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 224-230.) | [10] | Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity[J]. Nat Rev Immunol, 2021, 21(8): 485-498. | [11] | Jou E, Rodriguez-Rodriguez N, Ferreira AF, et al. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis[J]. Sci Immunol, 2022, 7(72): eabn0175. | [12] | Groth C, Hu XY, Weber R, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression[J]. Br J Cancer, 2019, 120(1): 16-25. | [13] | ?zkan B, Lim H, Park SG. Immunomodulatory function of myeloid-derived suppressor cells during B cell-mediated immune responses[J]. Int J Mol Sci, 2018, 19(5): 1468. | [14] | Ma TM, Renz BW, Ilmer M, et al. Myeloid-derived suppressor cells in solid tumors[J]. Cells, 2022, 11(2): 310. | [15] | Condamine T, Ramachandran I, Youn JI, et al. Regulation of tumor metastasis by myeloid-derived suppressor cells[J]. Annu Rev Med, 2015, 66: 97-110. | [16] | Safarzadeh E, Orangi M, Mohammadi H, et al. Myeloid-derived suppressor cells: important contributors to tumor progression and metastasis[J]. J Cell Physiol, 2018, 233(4): 3024-3036. | [17] | Cao SK, Pan W, Liu H, et al. Expression and activity of arginase from monocytic-type myeloid-derived suppressor cells in rats infected with Echinococcus granulosus[J]. Chin J Parasitol Parasit Dis, 2016, 34(1): 27-31. (in Chinese) | | (曹胜魁, 潘伟, 刘华, 等. 细粒棘球蚴感染小鼠单核髓源抑制性细胞精氨酸酶的表达和活性研究[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(1): 27-31.) | [18] | Zhang N, Zhang CS, Li ZD, et al. The effects of Echinococcus multilocularis protoscoleces infection on lymphocytes and their subpopulations in mouse liver and spleen[J]. Chin J Parasitol Parasit Dis, 2020, 38(1): 30-35. (in Chinese) | | (章宁, 张传山, 李智德, 等. 多房棘球蚴感染对小鼠肝脾淋巴细胞及其亚群的影响[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(1): 30-35.) | [19] | Zhang XF, Gong WC, Cao SK, et al. Dynamic changes of myeloid-derived suppressor cells and regulatory T cells in livers of mice infected with Echinococcus granulosus[J]. Chin J Schisto Control, 2019, 31(6): 622-627. (in Chinese) | | (张小凡, 巩文词, 曹胜魁, 等. 细粒棘球绦虫感染小鼠肝脏髓源抑制性细胞与调节性T细胞比例动态变化[J]. 中国血吸虫病防治杂志, 2019, 31(6): 622-627.) | [20] | Weber R, Riester Z, Hüser L, et al. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma[J]. J Immunother Cancer, 2020, 8(2): e000949. | [21] | Weber R, Groth C, Lasser S, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy[J]. Cell Immunol, 2021, 359: 104254. | [22] | Grover A, Sanseviero E, Timosenko E, et al. Myeloid-derived suppressor cells: a propitious road to clinic[J]. Cancer Discov, 2021, 11(11): 2693-2706. | [23] | Petrova V, Groth C, Bitsch R, et al. Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients[J]. Front Immunol, 2023, 14: 1065767. |
|